Better Chip Stock: Intel Versus Taiwan Semiconductor

The article argues for buying Taiwan Semiconductor Manufacturing (TSMC) over Intel, citing TSMC’s dominant foundry position (~72% revenue share) versus Intel’s smaller ~7% revenue contribution. It highlights that Intel’s expected growth is modest (analysts project ~11% revenue growth in 2026 and 2027), while TSMC is viewed as outpacing due to stronger momentum and demand tied to AI. Despite a noted geopolitical risk from Taiwan’s exposure, the piece says TSMC is expanding U.S. production and therefore remains the higher-quality, better-valued option.

Analysis

The real signal here is not “TSM is good” but that foundry optionality is becoming a bargaining chip for the largest OEMs. Even if Intel wins headline slots, the near-term economic transfer is likely modest unless it can prove node parity, yield, and capacity reliability; otherwise these deals are mostly procurement hedges that pressure TSM’s customer concentration without meaningfully displacing its advanced-node moat.

TSMC’s U.S. expansion is a margin trade-off: lower geopolitical discount and better political cover, but also higher capex intensity, more expensive labor, and a longer path to cash conversion than its legacy Taiwan base. The market may underappreciate that this can compress near-term ROIC even as it supports a higher terminal multiple; in other words, the stock can be right on strategy and wrong on timing.

Intel is the more interesting second-order setup. If management is using foundry headlines to re-rate the stock before operating proof, the risk is multiple compression once investors force the story to reconcile with revenue and gross margin data. Conversely, if a real external customer pipeline develops, that would matter over 6-18 months, not days, because foundry credibility is built on repeat orders and yield curves, not announcements.

Key Decisions for Investors

• Long TSM / short INTC as a relative-quality pair into the next 1-2 earnings cycles; thesis is that TSM’s earnings power is already real while Intel still needs proof. Falsify if Intel shows two consecutive quarters of accelerating foundry revenue and gross margin stabilization.
• Do not chase TSM strength on the headline alone; wait for any pullback tied to U.S. capex/margin concerns. The better entry is on commentary that U.S. buildout is dilutive before it is accretive.
• Use INTC as a sell-the-rally candidate on any additional partnership headlines unless accompanied by hard data on wafer starts, node mix, and customer concentration. The risk/reward is poor until the market can underwrite actual free-cash-flow improvement.
• Watch AAPL as a secondary beneficiary only if second-sourcing becomes contractual and multi-year; otherwise the leverage gain is strategic, not earnings-changing. No standalone trade unless there is evidence of meaningful volume migration away from TSM.